Literature DB >> 28861355

Prevalence of retinopathy of prematurity in Iran: a systematic review and Meta-analysis.

Saman Maroufizadeh1, Amir Almasi-Hashiani1, Reza Omani Samani1, Mahdi Sepidarkish1.   

Abstract

AIM: To estimate overall prevalence of retinopathy of prematurity (ROP) in Iran using a systematic review and Meta-analysis.
METHODS: A systematic review and Meta-analysis was performed of all published studies pertaining to prevalence of ROP using international and national electronic databases (ISI Web of Sciences, PubMed, Scopus, Google Scholar, SID, MagIran, and IranMedex) from their inception until May 2016 with standard keywords. Begg and Egger tests were used to examine the publication bias and Cochran test and I2 statistics were used to evaluate the statistical heterogeneity. Pooled estimate of the prevalence of ROP were calculated using random effects Meta-analysis.
RESULTS: The publication bias assumption was rejected by Egger tests with P-value equal to 0.024. The results of Cochran test and I2 statistics revealed substantial heterogeneity (Q=1099.02, df=25, I2=97.7%, P=0.001). The overall prevalence of ROP using the random effect model in Iran was 26.1% (95% CI: 20.3%-31.8%).
CONCLUSION: The prevalence of ROP is relatively high in Iran. Low birth weight and gestational age are significant risk factors for the disease. Improved care, including oxygen delivery and monitoring, for preterm babies in all facility settings would reduce the number of babies affected with ROP.

Entities:  

Keywords:  Iran; Meta-analysis; infant; preterm birth; retinopathy of prematurity; systematic review

Year:  2017        PMID: 28861355      PMCID: PMC5554848          DOI: 10.18240/ijo.2017.08.15

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  35 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

3.  Retinopathy of prematurity: risk factors in a prospective population-based study.

Authors:  B A Darlow; L J Horwood; R S Clemett
Journal:  Paediatr Perinat Epidemiol       Date:  1992-01       Impact factor: 3.980

4.  The effect of anemia on retinopathy of prematurity in extremely low birth weight infants.

Authors:  J A Englert; R A Saunders; D Purohit; T C Hulsey; M Ebeling
Journal:  J Perinatol       Date:  2001 Jan-Feb       Impact factor: 2.521

Review 5.  [Retinopathy of prematurity: clinical findings and current opinions on diagnosis and treatment].

Authors:  Monika Modrzejewska
Journal:  Ann Acad Med Stetin       Date:  2006

6.  Retinopathy of prematurity--risk factors.

Authors:  Ved P Gupta; Upreet Dhaliwal; Rohit Sharma; Piyush Gupta; Jolly Rohatgi
Journal:  Indian J Pediatr       Date:  2004-10       Impact factor: 1.967

7.  Retinopathy of prematurity: incidence, risk factors, and outcome.

Authors:  Mohammad Kazem Sabzehei; Seyyed Abolfazl Afjeh; Afsar Dastjani Farahani; Ahmad Reza Shamshiri; Fatemeh Esmaili
Journal:  Arch Iran Med       Date:  2013-09       Impact factor: 1.354

8.  Incidence and Risk Factors of Retinopathy of Prematurity among Preterm Infants in Shiraz/Iran.

Authors:  Mojgan Bayat-Mokhtari; Narjes Pishva; Abbas Attarzadeh; Hamid Hosseini; Shahnaz Pourarian
Journal:  Iran J Pediatr       Date:  2010-09       Impact factor: 0.364

9.  Retinopathy of Prematurity in Neonates and its Risk Factors: A Seven Year Study in Northern Iran.

Authors:  Seyed Ahmad Rasoulinejad; Mohammad Montazeri
Journal:  Open Ophthalmol J       Date:  2016-02-29

10.  Retinopathy of Prematurity: Single versus Multiple-Birth Pregnancies.

Authors:  Mohammad Riazi-Esfahani; Yousef Alizadeh; Reza Karkhaneh; Mohammad-Reza Mansouri; Maliheh Kadivar; Mahdi Nili Ahmadabadi; Fatemeh Nayeri
Journal:  J Ophthalmic Vis Res       Date:  2008-01
View more
  3 in total

1.  The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis.

Authors:  Junsheng Fan; Zengfei Xia; Xiaoli Zhang; Yuqing Chen; Ruolan Qian; Sihan Liu; Danming You; Jian Zhang; Peng Luo
Journal:  Onco Targets Ther       Date:  2018-03-01       Impact factor: 4.147

2.  Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine.

Authors:  Mohammad T Akkawi; Mohammad M Shehadeh; Amjaad N Abu Shams; Doaa M Al-Hardan; Lara J Omar; Omar H Almahmoud; Jamal A S Qaddumi
Journal:  BMC Ophthalmol       Date:  2019-08-20       Impact factor: 2.209

3.  Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity.

Authors:  Seyed Ahmad Rasoulinejad; Faezeh Maroufi; Ahad Alizadeh
Journal:  Caspian J Intern Med       Date:  2022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.